期刊
DALTON TRANSACTIONS
卷 41, 期 38, 页码 11798-11806出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/c2dt31360j
关键词
-
资金
- Australian Research Council
- National Health and Medical Research Council
- Monash University
- Monash University Postgraduate Publication Award Scheme
- Bayer Schering
- Victorian Government's Operational Infrastructure Support Program (MIMR)
Four new tris-substituted bismuth(III) sulfonates of general formula [Bi(O3SR)(3)] (R = phenyl 1, p-tolyl 2, 2,4,6-mesityl 3 and S-(+)-10-camphoryl 4) have been synthesised and characterised. Their synthesis by solvent-free (SF) and solvent-mediated (SM) methods has been explored and their activity against Helicobacter pylori has been investigated. The compounds 1-4 display a remarkable in vitro activity against three laboratory strains of H. pylori (B128, 26 695 and 251) with minimum inhibitory concentration (MIC) values as low as 0.049 mu g mL(-1) for the strains B128 and 26 695, and 0.781 mu g mL(-1) for the clinical isolate 251. This places most MIC values in the nano-molar region and demonstrates the strong influence of the sulfonate group on the bactericidal properties. The novel solid state structure [Bi-8(O(3)SMes)(20)(SO4)(2)(H2O)(6)]center dot(C7H8)(7) 5 center dot(C(7)H8)(7), derived from the SM reaction under reflux conditions, is presented and the incorporation of the two inorganic sulfate anions in the centre of the wheel-like bismuth sulfonate cluster explained.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据